In a statement published in the Journal of Clinical Endocrinology and Metabolism, physicians from Johns Hopkins School of Medicine acknowledge the challenges minority populations may face within the healthcare system. They pose a larger question: Why does disparity exist?
A deeper insight into the association between treatment with biologic disease-modifying antirheumatic drugs in rheumatic diseases and risk for type 2 diabetes.
An appreciation of the virtues one wishes to embody can help to navigate the complex ethical dilemmas physicians may face during the COVID-19 crisis.
In the event of a likely scarcity of COVID-19 vaccines, a framework must be developed to inform who should get priority.
Lipid-lowering therapies are key to the prevention of cardiovascular (CV) events and CV-related mortality.
In the United States, less than one-quarter of women eligible for bone mineral density testing are screened, leaving many women at risk for fractures.